Delivery Order SPE2DB22D2206-SPE2DB25FJM44
Award Date 8/19/25
Potential Completion Date 8/20/25
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a $1,945.44 firm fixed-price delivery order for QSYMIA 11.25 mg-69 mg capsules (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. The product...
- The Defense Logistics Agency awarded a $1,013.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Qsymia 7.5 mg-46 mg capsules (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 31, 2025, and performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $1,540 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply Qsymia 3.75 MG-23 MG capsules. The order was awarded on November 24, 2023, with performance to be completed by November 27, 2023. The location of performance will be Amerisourcebergen's headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this order placed against an...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,922.80 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Qsymia 3.75 mg-23 mg capsules in a 30-count package. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and no set-aside designation was utilized. The award represents a competitive procurement action through an open competition process. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,234.40, is for the delivery of the prescription medication Qsymia 3.75 mg-23 mg capsules. The contract is a firm fixed-price delivery order, with a performance period ending on May 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 7.5 mg-46 mg capsules of the drug Qsymia, with a ceiling value of $1,504.59 and a performance period ending on May 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $4,300.89 for Qualipita 60 mg tablets (30-count units) by the Defense Logistics Agency's Medical Supply Chain. The contract was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a competitively awarded, non-set-aside order under a firm fixed-price arrangement. The place of performance is located in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for the supply of Fycompa 2 mg tablets (30-count units) valued at $1,493.69. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,368.70 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025. The contract utilizes firm fixed pricing with no set-aside designation and is classified as a child contract under a larger vehicle. Performance is scheduled for completion by August 5, 2025, at the vendor's Conshohocken facility. This delivery order represents a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,991.18 by the Defense Logistics Agency Medical Supply Chain on July 26, 2025. The contract, designated as a firm fixed price delivery order with no set-aside provisions, represents a child award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...